Diabetic Macular Edema
📧 Sign up to get email alerts when something new happens for Diabetic Macular Edema.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-01-28Clinical Trial Update: Effect of Ruboxistaurin on Clinically Significant Macular Edema [Phase 3]
Phase 3 trial evaluating ruboxistaurin for clinically significant macular edema in diabetes has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Relating Retinal Structural and Functional Parameters to Visual Acuity in Eyes Undergoing Treatment for Diabetic Macular Edema
A completed clinical trial update examining how retinal structural and functional measurements relate to visual acuity in eyes treated for d…
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular ("Wet") Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME) [Phase 1]
Regeneron reports the completion of a Phase 1 study evaluating intravitreal REGN910-3 and REGN910 for neovascular age-related macular degene…
-
CLINICAL_TRIALS research · 2016-01-08Clinical Trial Update: Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Patients With Persistent Diabetic Macular Edema Following Treatment With Ranibizumab: An Interventional Prospective Study [Phase 4]
Phase 4 interventional prospective study assessing predictors of response to aflibercept and aqueous cytokine levels in patients with persis…
-
CLINICAL_TRIALS trial_result · 2016-01-06Clinical Trial Update: Efficacy of Ranibizumab Therapy With Aflibercept in Patients With Diabetic Macular Edema [Phase 4]
Phase 4 clinical trial evaluating the efficacy of combined ranibizumab and aflibercept therapy in diabetic macular edema; the study status i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-01-06Clinical Trial Update: Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing) [Phase 3]
Phase 3 safety and efficacy study of Conbercept for Diabetic Macular Edema (Sailing) is being conducted; the current trial status is unknown…
-
CLINICAL_TRIALS research · 2016-01-05Clinical Trial Update: The Effect of Bevacizumab and Ziv-aflibercept in Diabetic Macular Edema [Phase 2, Phase 3]
Clinical trial update on the effect of bevacizumab and ziv-aflibercept in diabetic macular edema. The study covers Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2015-12-16Clinical Trial Update: Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema [Phase 3]
Phase 3 comparative effectiveness study of intravitreal aflibercept, bevacizumab, and ranibizumab for diabetic macular edema has completed w…
-
CLINICAL_TRIALS withdrawal · 2015-12-11Clinical Trial Update: A Study of the Safety and Tolerability of Intravitreal LKA651 in Patients With Diabetic Macular Edema [Phase 1]
Phase 1 study evaluating intravitreal LKA651 for diabetic macular edema has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: The Effect of Intravitreal Ozurdex on DME After Cataract Surgery [Phase 3]
Phase 3 trial evaluating intravitreal Ozurdex for diabetic macular edema following cataract surgery has completed.
-
CLINICAL_TRIALS research · 2015-11-25Clinical Trial Update: Spectral-domain Optical Coherence Tomography of the Eye
Clinical trial update describing the use of spectral-domain optical coherence tomography to evaluate ocular conditions, including corneal an…
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema [Phase 4]
A Phase 4 trial comparing anti-VEGF therapy alone versus Ozurdex (dexamethasone intravitreal implant) given every 3 months for persistent di…
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: A Study of MK0140 in Diabetic Patients With Macular Edema (0140-001) [Phase 2]
A Phase 2 study of MK0140 in diabetic patients with macular edema has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-10-28Clinical Trial Update: Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy
The completed trial evaluated changes in visual acuity in patients with diabetic macular edema who started treatment with an approved anti-V…
-
CLINICAL_TRIALS trial_result · 2015-10-26Clinical Trial Update: A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study evaluating MTP-131 topical ophthalmic solution for diabetic macular e…
-
CLINICAL_TRIALS trial_result · 2015-10-15Clinical Trial Update: Validation of a New Methodology for Mapping the Human Blood-Retinal Barrier Function
Clinical trial update reporting completion of a study validating a new methodology for mapping the human blood-retinal barrier function, inv…
-
CLINICAL_TRIALS trial_result · 2015-09-22Clinical Trial Update: Grid Laser for Diffuse Diabetic Maculopathy
A clinical trial evaluating grid laser treatment for diffuse diabetic macular edema has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-16Clinical Trial Update: A Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Corticosteroid Therapy [Phase 4]
A Phase 4, non-randomized, open-label study assessing the effect and safety of the ILUVIEN fluocinolone acetonide intravitreal implant in ch…
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: Observational Study to Assess the Effect of Iluvien® in DME Patients Insufficiently Responsive to Available Therapies
Observational study assessing the effect of Iluvien (fluocinolone acetonide intravitreal implant) in diabetic macular edema patients unrespo…
-
CLINICAL_TRIALS trial_result · 2015-07-14Clinical Trial Update: A Study of Abicipar Pegol in Patients With Diabetic Macular Edema [Phase 2]
A Phase 2 trial evaluating Abicipar Pegol for diabetic macular edema has completed.
-
CLINICAL_TRIALS research · 2015-07-01Clinical Trial Update: Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME) [Phase 2, Phase 3]
This clinical trial update compares bevacizumab to ranibizumab for diabetic macular edema, evaluating effectiveness and costs in Phase 2 and…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Dextromethorphan for Diabetic Macular Edema [Phase 1, Phase 2]
Phase 1/2 clinical trial investigating dextromethorphan for diabetic macular edema completed with posted results in 2015.
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema [Phase 2]
Phase 2 trial comparing intravitreal bevacizumab (Avastin) with intravitreal dexamethasone (Ozurdex) for persistent diabetic macular edema h…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Safety and Tolerability of NOVA63035 "Corticosteroid" in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy [Phase 1]
Phase 1 trial update evaluating the safety and tolerability of NOVA63035, a corticosteroid, in patients with diabetic macular edema due to d…
-
FDA approval · 2015-05-18FDA Approved: ILUVIEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application from ANI Pharmaceuticals to add a new manufacturer for ILUVIEN (fluocinolone acetonide) under the ex…